{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:47:55Z","timestamp":1769104075594,"version":"3.49.0"},"reference-count":20,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,1]]},"abstract":"<jats:p>Guillain-Barr\u00e9 syndrome (GBS) is characterized by a monophasic, ascending, and symmetrical paralysis with areflexia that progresses over days to weeks. It is typically a postinfectious autoimmune process that leads to destruction of myelin. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), originated in Wuhan, China, in late 2019 and rapidly spread around the world, causing a pandemic of novel coronavirus disease 2019 (COVID-19). There have been scattered reports of adults with possible GBS and concurrent evidence of COVID-19, but no previous reports in children. The patient is an 8-year-old boy who presented to the emergency department with progressive, ascending weakness with areflexia. He was intubated for airway protection because of poor secretion control. MRI of the spine revealed abnormal enhancement of posterior nerve roots. A lumbar puncture revealed albuminocytologic dissociation with 1 nucleated cell per mm3 and a protein level of 620 mg\/dL. Electrodiagnostic findings were compatible with sensorimotor demyelinating polyneuropathy. The lumbar puncture, MRI, and electrodiagnostics were all consistent with GBS. Results of SARS-CoV-2 nucleic acid amplification and SARS-CoV-2 immunoglobulin G antibody tests were positive. Treatment was initiated with intravenous immunoglobulin; he received a total of 2 g\/kg. His neurologic examination revealed improvement in the subsequent days. He was extubated after 4 days of intubation. This case is the first reported case of a child with GBS in the setting of an acute COVID-19 infection. This case reveals the wide scope of presentations of COVID-19 and postinfectious processes. Clinicians should constantly have a high level of suspicion for COVID-19.<\/jats:p>","DOI":"10.1542\/peds.2020-015115","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T12:35:19Z","timestamp":1603370119000},"source":"Crossref","is-referenced-by-count":31,"title":["Guillain-Barr\u00e9 Syndrome in a Child With COVID-19 Infection"],"prefix":"10.1542","volume":"147","author":[{"given":"Molly","family":"Curtis","sequence":"first","affiliation":[{"name":"Division of Pediatric Emergency Medicine and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samina","family":"Bhumbra","sequence":"additional","affiliation":[{"name":"Ryan White Center for Pediatric Infectious Disease and Global Health,"},{"name":"Department of Pediatrics, Indiana University and Riley Hospital for Children, Indianapolis, Indiana; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia V.","family":"Felker","sequence":"additional","affiliation":[{"name":"Departments of Neurology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany L.","family":"Jordan","sequence":"additional","affiliation":[{"name":"Departments of Neurology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Indiana University and Riley Hospital for Children, Indianapolis, Indiana; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Weber","sequence":"additional","affiliation":[{"name":"Emergency Medicine, Indiana University, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew L.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"issue":"3","key":"2021121008102819600_B1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/088307380001500308","article-title":"New concepts of Guillain-Barr\u00e9 syndrome","volume":"15","author":"Asbury","year":"2000","journal-title":"J Child Neurol"},{"key":"2021121008102819600_B2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pediatrneurol.2020.01.017","article-title":"Pediatric Guillain-Barr\u00e9 syndrome in a 30-year nationwide cohort","volume":"107","author":"Levison","year":"2020","journal-title":"Pediatr Neurol"},{"issue":"6","key":"2021121008102819600_B3","doi-asserted-by":"crossref","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 among children in China","volume":"145","author":"Dong","year":"2020","journal-title":"Pediatrics"},{"issue":"9","key":"2021121008102819600_B4","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamapediatrics.2020.1467","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review","volume":"174","author":"Castagnoli","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"6","key":"2021121008102819600_B5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"issue":"1","key":"2021121008102819600_B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ana.25807","article-title":"COVID-19: a global threat to the nervous system","volume":"88","author":"Koralnik","year":"2020","journal-title":"Ann Neurol"},{"issue":"8","key":"2021121008102819600_B7","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/ene.14329","article-title":"Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2","volume":"27","author":"Vonck","year":"2020","journal-title":"Eur J Neurol"},{"issue":"4","key":"2021121008102819600_B8","doi-asserted-by":"crossref","first-page":"e741","DOI":"10.1212\/NXI.0000000000000741","article-title":"Guillain-Barr\u00e9 syndrome related to COVID-19 infection","volume":"7","author":"Alberti","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"2021121008102819600_B9","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s10072-020-04449-8","article-title":"Early Guillain-Barr\u00e9 syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital","volume":"41","author":"Ottaviani","year":"2020","journal-title":"Neurol Sci"},{"issue":"6","key":"2021121008102819600_B10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.neurol.2020.04.003","article-title":"COVID-19 may induce Guillain-Barr\u00e9 syndrome","volume":"176","author":"Camdessanche","year":"2020","journal-title":"Rev Neurol (Paris)"},{"issue":"5","key":"2021121008102819600_B11","doi-asserted-by":"crossref","first-page":"e781","DOI":"10.1212\/NXI.0000000000000781","article-title":"Guillain-Barr\u00e9 syndrome: the first documented COVID-19-triggered autoimmune neurologic disease: more to come with myositis in the offing","volume":"7","author":"Dalakas","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"2021121008102819600_B12","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s10072-020-04484-5","article-title":"New clinical manifestation of COVID-19 related Guillain-Barre syndrome highly responsive to intravenous immunoglobulins: two Italian cases. [published correction appears in Neurol Sci. 2020;41(8):2307]","volume":"41","author":"Assini","year":"2020","journal-title":"Neurol Sci"},{"issue":"26","key":"2021121008102819600_B13","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N Engl J Med"},{"key":"2021121008102819600_B14","author":"Centers for Disease Control and Prevention","year":"2020"},{"issue":"3","key":"2021121008102819600_B15","first-page":"2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. [published corrections appear in Euro Surveill. 2020;25(14):20200409c and Euro Surveill. 2020;25(30):2007303]","volume":"25","author":"Corman","year":"2020","journal-title":"Euro Surveill"},{"issue":"3","key":"2021121008102819600_B16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4103\/1817-1745.165716","article-title":"A rare cause of acute flaccid paralysis: human coronaviruses","volume":"10","author":"Turgay","year":"2015","journal-title":"J Pediatr Neurosci"},{"issue":"7","key":"2021121008102819600_B17","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3174\/ajnr.A6609","article-title":"COVID-19-associated Miller Fisher syndrome: MRI findings","volume":"41","author":"Lantos","year":"2020","journal-title":"AJNR Am J Neuroradiol"},{"key":"2021121008102819600_B18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","article-title":"Guillain Barre syndrome associated with COVID-19 infection: a case report","volume":"76","author":"Sedaghat","year":"2020","journal-title":"J Clin Neurosci"},{"issue":"5","key":"2021121008102819600_B19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet Neurol"},{"issue":"6","key":"2021121008102819600_B20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-015115\/1181798\/peds_2020015115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-015115\/1181798\/peds_2020015115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T20:02:19Z","timestamp":1639166539000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/147\/4\/e2020015115\/180802\/Guillain-Barre-Syndrome-in-a-Child-With-COVID-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,1]]},"published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2020-015115","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"article-number":"e2020015115"}}